John Abramson

John Abramson is a healthcare policy expert, physician, and faculty member at Harvard Medical School, where he has taught healthcare policy for over two decades. He is known for his critical analysis of the pharmaceutical industry and his advocacy for evidence-based medicine and healthcare reform. His 2004 book "Overdosed America: The Broken Promise of American Medicine" exposed how commercial interests influence medical research and clinical practice. His 2021 book "Sickening: How Big Pharma Broke American Health Care and How We Can Repair It" examines the pharmaceutical industry's impact on U.S. healthcare costs and patient outcomes. As an expert witness in pharmaceutical litigation, Abramson has provided testimony in major cases involving drug safety and marketing practices. His research and writing focus on the intersection of commercial interests and medical science, particularly how industry funding affects clinical trials and medical knowledge. Abramson's work has appeared in academic journals including The Lancet and the Journal of the American Medical Association (JAMA), as well as major media outlets. He continues to practice primary care medicine while advocating for greater transparency in medical research and pharmaceutical industry practices.

Readers appreciate Abramson's detailed research and clear explanations of complex healthcare issues. Many cite his ability to expose pharmaceutical industry practices while offering concrete solutions. Multiple reviewers noted his effective use of data and case studies to support his arguments. Liked: - Clear breakdown of how drug pricing works - Well-documented examples of industry influence on medical research - Practical recommendations for system reform Disliked: - Some found the technical details overwhelming - A few readers wanted more focus on potential solutions - Critics noted repetitive points in certain chapters Ratings: - "Sickening" (2021): 4.5/5 on Amazon (248 reviews), 4.3/5 on Goodreads (392 ratings) - "Overdosed America" (2004): 4.6/5 on Amazon (156 reviews), 4.1/5 on Goodreads (276 ratings) One reader commented: "Finally, someone explains why healthcare costs so much without resorting to political talking points." Another noted: "The statistics and research citations can be dense, but they're necessary to prove his case."

Overdosed America: The Broken Promise of American Medicine (2004) Examines how commercial interests have influenced medical research and healthcare delivery in the United States, analyzing the impact on clinical practice and patient care.

Sickening: How Big Pharma Broke American Health Care and How We Can Repair It (2021) Details the pharmaceutical industry's role in driving up healthcare costs and affecting patient outcomes, while proposing solutions for healthcare system reform.

Marcia Angell - Former editor-in-chief of the New England Journal of Medicine who writes about pharmaceutical industry influence on medicine. Her book "The Truth About the Drug Companies" examines how marketing drives pharmaceutical research and development.

Ben Goldacre - Physician and epidemiologist who investigates problems in medical research and pharmaceutical testing. His work "Bad Pharma" documents how drug companies misrepresent clinical trials and withhold negative data.

Jerome Kassirer - Former editor of the New England Journal of Medicine who explores conflicts of interest in medicine. His book "On the Take" examines how financial relationships between doctors and drug companies affect patient care.

Peter Gøtzsche - Co-founder of the Cochrane Collaboration who researches pharmaceutical industry practices and clinical trial transparency. His book "Deadly Medicines and Organised Crime" analyzes how pharmaceutical companies influence medical research and practice.

David Healy - Psychiatrist who studies pharmaceutical industry marketing and adverse drug effects. His book "Pharmageddon" examines how pharmaceutical company practices have changed the practice of medicine and patient care.